NO147300C - Analogifremgangsmaate for fremstilling av antivirale amin-derivater - Google Patents

Analogifremgangsmaate for fremstilling av antivirale amin-derivater

Info

Publication number
NO147300C
NO147300C NO782791A NO782791A NO147300C NO 147300 C NO147300 C NO 147300C NO 782791 A NO782791 A NO 782791A NO 782791 A NO782791 A NO 782791A NO 147300 C NO147300 C NO 147300C
Authority
NO
Norway
Prior art keywords
antiviral
preparation
amine derivatives
analogy procedure
analogy
Prior art date
Application number
NO782791A
Other languages
English (en)
Norwegian (no)
Other versions
NO782791L (no
NO147300B (no
Inventor
Allen Richard Kraska
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO782791L publication Critical patent/NO782791L/no
Publication of NO147300B publication Critical patent/NO147300B/no
Publication of NO147300C publication Critical patent/NO147300C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24—Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/06—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted
    • C07C217/08—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one etherified hydroxy group and one amino group bound to the carbon skeleton, which is not further substituted the oxygen atom of the etherified hydroxy group being further bound to an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/62—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
    • C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
    • C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/02—Ethers
    • C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
    • C07C43/14—Unsaturated ethers
    • C07C43/15—Unsaturated ethers containing only non-aromatic carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/52—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings
    • C07C47/575—Compounds having —CHO groups bound to carbon atoms of six—membered aromatic rings containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO782791A 1977-08-18 1978-08-17 Analogifremgangsmaate for fremstilling av antivirale amin-derivater NO147300C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/825,535 US4166132A (en) 1977-08-18 1977-08-18 Antiviral amine derivatives of glycerol and propanediols

Publications (3)

Publication Number Publication Date
NO782791L NO782791L (no) 1979-02-20
NO147300B NO147300B (no) 1982-12-06
NO147300C true NO147300C (no) 1983-03-16

Family

ID=25244254

Family Applications (3)

Application Number Title Priority Date Filing Date
NO782791A NO147300C (no) 1977-08-18 1978-08-17 Analogifremgangsmaate for fremstilling av antivirale amin-derivater
NO81813324A NO154344C (no) 1977-08-18 1981-09-30 Analogifremgangsmaate for fremstilling av antivirale amin- og amidin-derivater.
NO813325A NO147670C (no) 1977-08-18 1981-09-30 Analogifremgangsmaate for fremstilling av antivirale amin-derivater.

Family Applications After (2)

Application Number Title Priority Date Filing Date
NO81813324A NO154344C (no) 1977-08-18 1981-09-30 Analogifremgangsmaate for fremstilling av antivirale amin- og amidin-derivater.
NO813325A NO147670C (no) 1977-08-18 1981-09-30 Analogifremgangsmaate for fremstilling av antivirale amin-derivater.

Country Status (35)

Country Link
US (1) US4166132A (ja)
JP (3) JPS5829939B2 (ja)
AR (2) AR219543A1 (ja)
AT (1) AT363922B (ja)
AU (1) AU503079B1 (ja)
BE (1) BE869793A (ja)
CA (1) CA1102354A (ja)
CH (1) CH634544A5 (ja)
CS (1) CS208155B2 (ja)
DD (2) DD148951A5 (ja)
DE (3) DE2835369C2 (ja)
DK (1) DK149022C (ja)
EG (1) EG13438A (ja)
ES (3) ES472659A1 (ja)
FI (1) FI67687C (ja)
FR (2) FR2421871A1 (ja)
GB (1) GB2005248B (ja)
GR (1) GR73154B (ja)
HU (2) HU177884B (ja)
IE (1) IE47151B1 (ja)
IL (1) IL55370A (ja)
IN (1) IN148386B (ja)
IT (1) IT1098280B (ja)
LU (1) LU80114A1 (ja)
MX (1) MX6091E (ja)
NL (1) NL176670C (ja)
NO (3) NO147300C (ja)
NZ (1) NZ188174A (ja)
PH (4) PH16469A (ja)
PL (3) PL116434B1 (ja)
PT (1) PT68426A (ja)
SE (3) SE447823B (ja)
SU (3) SU893128A3 (ja)
YU (3) YU41115B (ja)
ZA (1) ZA783855B (ja)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4173641A (en) * 1978-05-15 1979-11-06 Pfizer Inc. Di-O-n-alkyl glycerol derivatives as immune stimulants
US4255426A (en) * 1979-07-09 1981-03-10 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted-piperazines and piperidines
YU41932B (en) * 1979-07-09 1988-02-29 Pfizer Process for obtaining substituted piperazines and piperidi
US4312877A (en) * 1979-07-09 1982-01-26 Pfizer Inc. 1-(2-Hydroxy-3-n-alkoxypropyl)-4-substituted piperidines, pharmaceutical compositions, thereof and use thereof
EP0094586A3 (en) * 1982-05-13 1984-06-06 Ono Pharmaceutical Co., Ltd. Glycerol derivatives, process for preparing same and pharmaceutical composition containing same
JPS5988447A (ja) * 1982-11-11 1984-05-22 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
JPS60100544A (ja) * 1983-11-08 1985-06-04 Ono Pharmaceut Co Ltd 新規なグリセリン誘導体，その製造方法及びその誘導体を含有する薬剤
JPS60104066A (ja) * 1983-11-10 1985-06-08 Ono Pharmaceut Co Ltd グリセリン誘導体
JPS60105650A (ja) * 1983-11-14 1985-06-11 Ono Pharmaceut Co Ltd グリセリン誘導体、その製造方法及びその誘導体を含有する薬剤
JPS6164353A (ja) * 1984-09-04 1986-04-02 川崎重工業株式会社 湿式ミルの運転方法
JPS6194657A (ja) * 1984-10-16 1986-05-13 武田薬品工業株式会社 バイアル用ゴム栓
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5550289A (en) * 1985-01-07 1996-08-27 Syntex (U.S.A.) Inc. N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
CA1291036C (en) * 1986-04-23 1991-10-22 Edwin I. Stoltz Nasal administration of drugs
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
JPS63166237U (ja) * 1987-04-16 1988-10-28
US5093198A (en) * 1987-06-19 1992-03-03 Temple University Adjuvant-enhanced sustained release composition and method for making
JPH0244750Y2 (ja) * 1988-03-18 1990-11-28
AU614636B2 (en) * 1988-07-21 1991-09-05 Ciba Specialty Chemicals Holding Inc. Corrosion inhibition
US5176850A (en) * 1988-07-21 1993-01-05 Ciba-Geigy Corporation Substituted glycerol compounds
ZA899436B (en) * 1988-12-12 1990-08-29 Ciba Geigy Piperidine derivatives
JP2604268B2 (ja) * 1990-04-09 1997-04-30 富士写真フイルム株式会社 ペプチド誘導体両親媒性化合物、その中間体、ペプチド誘導体両親媒性化合物を用いたリポソームおよび薄膜
JPH0439597A (ja) * 1990-06-01 1992-02-10 Corona:Kk 給湯装置の熱交換器
DE19521412A1 (de) * 1995-06-14 1996-12-19 Boehringer Mannheim Gmbh Neue kationische und polykationische Amphiphile, diese enthaltende Reagenzien und deren Verwendung
DE19755268A1 (de) * 1997-12-12 1999-06-17 Merck Patent Gmbh Benzamidinderivate
GB0106041D0 (en) * 2001-03-12 2001-05-02 Cancer Res Ventures Ltd Lipids and liposomes
US7615604B2 (en) * 2003-01-17 2009-11-10 The United States Of America As Represented By The Secretary Of The Navy Diols formed by ring-opening of epoxies
US7622541B2 (en) * 2003-01-17 2009-11-24 The United States Of America As Represented By The Secretary Of The Navy Polyurethane coating
WO2009129385A1 (en) * 2008-04-16 2009-10-22 Abbott Laboratories Cationic lipids and uses thereof
WO2009129387A2 (en) * 2008-04-16 2009-10-22 Abbott Laboratories Cationic lipids and uses thereof
WO2009129395A1 (en) * 2008-04-16 2009-10-22 Abbott Laboratories Cationic lipids and uses thereof
EP2348864A4 (en) 2008-10-08 2013-07-31 Vascular Biogenics Ltd OXIDIZED THIOPHOSPHOLIPID COMPOUNDS AND USES THEREOF
EP2826369A3 (en) 2008-11-06 2015-03-18 Vascular Biogenics Ltd. Oxidized lipid compounds and uses thereof
EA026374B1 (ru) 2009-12-23 2017-04-28 Новартис Аг Липиды, липидные композиции и способы их применения
US10342761B2 (en) 2014-07-16 2019-07-09 Novartis Ag Method of encapsulating a nucleic acid in a lipid nanoparticle host
US9771385B2 (en) 2014-11-26 2017-09-26 Vascular Biogenics Ltd. Oxidized lipids
EP3223824B1 (en) 2014-11-26 2021-01-06 Vascular Biogenics Ltd. Oxidized lipids and treatment or prevention of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2738351A (en) * 1952-08-02 1956-03-13 Bristol Lab Inc Substituted glycerol ethers
GB1013603A (en) * 1961-06-08 1965-12-15 Sandoz Ltd Level-dyeing process
GB1369249A (en) * 1970-08-07 1974-10-02 Pfizer Amines the preparation thereof and their use in pharmaceutical compositions
US3960958A (en) * 1974-08-26 1976-06-01 Pfizer Inc. 3,4- AND 3,5-Dialkoxybenzylamines
US4025555A (en) * 1976-07-23 1977-05-24 Pfizer Inc. Aromatic amidines as antiviral agents in animals

Also Published As

Publication number Publication date
DD148951A5 (de) 1981-06-17
SE8401849D0 (sv) 1984-04-03
GR73154B (ja) 1984-02-13
NO782791L (no) 1979-02-20
ATA600278A (de) 1981-02-15
DK149022C (da) 1986-10-13
AR218733A1 (es) 1980-06-30
PH17789A (en) 1984-12-13
ES479616A1 (es) 1979-08-01
FI67687B (fi) 1985-01-31
ES479615A1 (es) 1979-08-01
NO147300B (no) 1982-12-06
NL7808565A (nl) 1979-02-20
IT1098280B (it) 1985-09-07
DE2857416C2 (de) 1984-05-24
JPS57167966A (en) 1982-10-16
DE2835369A1 (de) 1979-02-22
SE7808701L (sv) 1979-02-19
IN148386B (ja) 1981-02-07
YU262982A (en) 1983-04-30
PH18067A (en) 1985-03-18
FI782518A (fi) 1979-02-19
LU80114A1 (fr) 1980-04-21
SE463456B (sv) 1990-11-26
AR219543A1 (es) 1980-08-29
JPS57167913A (en) 1982-10-16
NZ188174A (en) 1984-07-31
JPS5441807A (en) 1979-04-03
MX6091E (es) 1984-11-12
YU263082A (en) 1983-04-30
US4166132A (en) 1979-08-28
NO147670C (no) 1983-05-25
SE8401850D0 (sv) 1984-04-03
DE2835369C2 (de) 1982-12-02
PL116434B1 (en) 1981-06-30
PH16469A (en) 1983-10-21
YU41277B (en) 1986-12-31
GB2005248A (en) 1979-04-19
NL176670C (nl) 1985-05-17
NO147670B (no) 1983-02-14
PL115777B1 (en) 1981-04-30
DE2857415C2 (de) 1985-02-07
JPS5829939B2 (ja) 1983-06-25
DD143902A5 (de) 1980-09-17
CS208155B2 (en) 1981-08-31
SE447823B (sv) 1986-12-15
JPS5924144B2 (ja) 1984-06-07
CA1102354A (en) 1981-06-02
ES472659A1 (es) 1979-10-16
DK149022B (da) 1985-12-23
SU850005A3 (ru) 1981-07-23
IL55370A0 (en) 1978-10-31
SE8401849L (sv) 1984-04-03
SU893128A3 (ru) 1981-12-23
IL55370A (en) 1981-11-30
NO813324L (no) 1979-02-20
AT363922B (de) 1981-09-10
IE781658L (en) 1979-02-18
JPS5929582B2 (ja) 1984-07-21
NO154344B (no) 1986-05-26
IE47151B1 (en) 1983-12-28
FR2421871B1 (ja) 1982-07-02
SU906363A3 (ru) 1982-02-15
HU181238B (en) 1983-06-28
NO813325L (no) 1979-02-20
YU197478A (en) 1983-02-28
IT7826813A0 (it) 1978-08-17
PT68426A (en) 1978-09-01
FR2421871A1 (fr) 1979-11-02
NL176670B (nl) 1984-12-17
PL209092A1 (pl) 1979-06-04
FR2414038A1 (fr) 1979-08-03
HU177884B (en) 1982-01-28
PH18111A (en) 1985-03-22
AU503079B1 (en) 1979-08-23
FI67687C (fi) 1985-05-10
FR2414038B1 (ja) 1982-07-02
DK321478A (da) 1979-02-19
YU41115B (en) 1986-12-31
PL116119B1 (en) 1981-05-30
CH634544A5 (fr) 1983-02-15
EG13438A (en) 1981-12-31
NO154344C (no) 1986-09-03
YU41276B (en) 1986-12-31
ZA783855B (en) 1979-07-25
SE8401850L (sv) 1984-04-03
BE869793A (fr) 1979-02-19
GB2005248B (en) 1982-03-24

Similar Documents

Publication Publication Date Title
NO147300C (no) Analogifremgangsmaate for fremstilling av antivirale amin-derivater
DK148280C (da) Analogifremgangsmaade til fremstilling af thienothiazinderivater
DK155367C (da) Analogifremgangsmaade til fremstilling af 2-nitroimidazolderivater
DK63178A (da) Fremgangsmaade til fremstilling af pyrrodinderivater
DK536178A (da) Fremgangsmaade til fremstilling af stilbenderivater
DK149954C (da) Analogifremgangsmaade til fremstilling af 18-umaettede prostacyklinderivater
DK153482C (da) Analogifremgangsmaade til fremstilling af 5-cyano-prostacyklinderivater
SE420314B (sv) Analogiforfarande for framstellning av indolizinderivat
DK39778A (da) Fremgangsmaade til fremstilling af ethoxyquinderivater
DK154137C (da) Analogifremgangsmaade til fremstilling af meta-sulfonamido-benzamidderivater
DK30578A (da) Fremgangsmaade til fremstilling af aminoalkoxyphenylderivater
SE7803035L (sv) Forfarande for framstellning av tienopyridinderivat
NO784382L (no) Fremgangsmaate for fremstilling av tiazoldin-derivater
DK50778A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
AR211570A1 (es) Procedimiento de preparacion de nuevos derivados de 8-oxi-5-(2-hidroxi-3-aminopropoxi)-carbostirilo
NO153260C (no) Analogifremgangsmaate for fremstilling av antiviralt virksomme 9-hydroksyetoksyguaninderivater
DK50878A (da) Fremgangsmaade til fremstilling af oxadiazolopyrimidinderivater
NO781928L (no) Fremgangsmaate til fremstilling av guanidinderivater
NO780389L (no) Fremgangsmaate for fremstilling av erytromycin-derivater
SE419083B (sv) Analogiforfarande for framstellning av nikotinoylamino-triazinderivat
DK246878A (da) Fremgangsmaade til fremstilling af acylderivater
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
DK61778A (da) Fremgangsmaade til fremstilling af everninominderivater
DK147072C (da) Analogifremgangsmaade til fremstilling af ergolenderivater
NO780834L (no) Fremgangsmaate for fremstilling av isobutyramid-derivater